End-of-day quote
Shanghai S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
8.6
CNY
|
+1.90%
|
|
-0.12%
|
-5.70%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Capitalization
1 |
6,940
|
8,880
|
20,446
|
17,347
|
12,308
|
11,607
|
Enterprise Value (EV)
1 |
6,940
|
8,880
|
20,446
|
17,347
|
12,308
|
11,607
|
P/E ratio
|
18.2
x
|
13.1
x
|
7.72
x
|
5.87
x
|
75.6
x
|
9.05
x
|
Yield
|
2.03%
|
-
|
2%
|
4.95%
|
1.1%
|
8.26%
|
Capitalization / Revenue
|
0.63
x
|
-
|
1.08
x
|
0.8
x
|
0.84
x
|
0.63
x
|
EV / Revenue
|
0.63
x
|
-
|
1.08
x
|
0.8
x
|
0.84
x
|
0.63
x
|
EV / EBITDA
|
-
|
-
|
5.41
x
|
4.21
x
|
12.6
x
|
5.26
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
1.22
x
|
-
|
2.29
x
|
1.5
x
|
0.98
x
|
0.82
x
|
Nbr of stocks (in thousands)
|
987,398
|
1,145,805
|
1,145,457
|
1,145,747
|
1,349,597
|
1,349,597
|
Reference price
2 |
7.029
|
7.750
|
17.85
|
15.14
|
9.120
|
8.600
|
Announcement Date
|
4/29/20
|
3/30/21
|
3/21/22
|
4/14/23
|
4/25/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net sales
1 |
10,957
|
-
|
18,977
|
21,803
|
14,631
|
18,518
|
EBITDA
1 |
-
|
-
|
3,782
|
4,121
|
978.7
|
2,205
|
EBIT
1 |
558
|
-
|
3,217
|
3,530
|
342.5
|
1,374
|
Operating Margin
|
5.09%
|
-
|
16.95%
|
16.19%
|
2.34%
|
7.42%
|
Earnings before Tax (EBT)
1 |
548.1
|
-
|
3,143
|
3,473
|
309.2
|
1,374
|
Net income
1 |
378.2
|
585.1
|
2,654
|
2,955
|
140.2
|
1,086
|
Net margin
|
3.45%
|
-
|
13.99%
|
13.55%
|
0.96%
|
5.86%
|
EPS
2 |
0.3857
|
0.5929
|
2.313
|
2.579
|
0.1206
|
0.9500
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.1429
|
-
|
0.3571
|
0.7500
|
0.1000
|
0.7100
|
Announcement Date
|
4/29/20
|
3/30/21
|
3/21/22
|
4/14/23
|
4/25/24
|
-
|
Fiscal Period: December |
2023 Q1
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
106.2
|
Net margin
|
-
|
EPS
2 |
0.0927
|
Dividend per Share
|
-
|
Announcement Date
|
4/27/23
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
6.67%
|
-
|
34.4%
|
29%
|
1.24%
|
9.4%
|
ROA (Net income/ Total Assets)
|
3.6%
|
-
|
17.9%
|
16.2%
|
-
|
5.7%
|
Assets
1 |
10,500
|
-
|
14,830
|
18,222
|
-
|
19,053
|
Book Value Per Share
2 |
5.770
|
-
|
7.810
|
10.10
|
9.350
|
10.50
|
Cash Flow per Share
2 |
0.8800
|
-
|
2.500
|
2.540
|
0.2100
|
1.770
|
Capex
1 |
827
|
-
|
809
|
1,351
|
1,468
|
2,044
|
Capex / Sales
|
7.55%
|
-
|
4.26%
|
6.2%
|
10.03%
|
11.04%
|
Announcement Date
|
4/29/20
|
3/30/21
|
3/21/22
|
4/14/23
|
4/25/24
|
-
|
Average target price
12
CNY Spread / Average Target +39.53% Consensus |
1st Jan change
|
Capi.
|
---|
| -5.70% | 1.6B | | +1.19% | 3.58B | | -17.77% | 2.21B | | -0.69% | 1.8B | | -13.26% | 1.85B | | -2.11% | 1.27B | | -2.91% | 1.1B | | -22.97% | 1.02B | | -8.05% | 951M | | +5.47% | 846M |
Pesticide
|